- Lead Story: NMPA Regulatory Approval Process for Medical Devices
- A Fresh Look at Digital Transformation in Life Sciences R&D Processes
- Global Regulatory Publishing Trends
- Prerequisites for Cosmetic Ingredient Listing in Health Canada
- Scientific Writing: A Lifeline Communication between the Creator and the Audience
- Nutraceutical Regulations: A Country-by-Country Review of Global Regulatory Requirements
- Revolutionize Regulatory Publishing & Submission with Automation
- Circular Economy: A New Era in the Polymer World
- Comparative Analysis of Dossier Submissions - EU & US
- WHO Considerations for Regulating Cell and Gene Therapy Products (CGTPs)
- Sunscreens in Australia: A Regulatory Overview
- Darwin EU® - EMA’s Initiative for RWE Integration in Medicines Assessment
- Pharmaceutical Promotional Material - Global Laws Overivew
- Alert Signal – The Vital Trigger for Pharmacovigilance Activities
- US Agent and Top 15 Frequently Asked Questions (FAQs)
- CSV or CSA? Which one is a Cost Saving Approach in 2022?
- Regulatory Intelligence (RI): The Focal Point of your Business
- Labeling Claims for Food and Food Supplements in The USA
- What is SFDA/CFDA/NMPA?
- Serialization - A Key Tenet
- Does the Prime Pathway Benefit your New Chemical Entity (NCE)?
- ePI Labeling – an Overview
- What is JPAL?
- Infographic: Medical Devices Risk Classification in Japan
- Infographic: Food Notification Process in Japan
- Infographic: Notification Process of Cosmetics in Japan
- Case Study: Successful ANDA and PADER Submissions with Zero Defects
- Case Study: RIMS Support for a Japan-based Healthcare Organization
- Testimonials
We appreciate your interest in Freyr CONNECT, a quarterly newsletter. We request you to kindly click on the individual topics, provided below, that may be of interest to you, and/or click on the download button at the bottom to get an exclusive copy of entire newsletter.
In addition, click on the subscribe button in the right section, so that you can automatically receive a new Issue of Freyr CONNECT, as soon as it is published.